3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome

Dev Med Child Neurol. 2000 Sep;42(9):629-33. doi: 10.1017/s0012162200001171.

Abstract

3-phosphoglycerate dehydrogenase deficiency is a severe but treatable disorder of serine synthesis, first described in 1996 (Jaeken et al. 1996a). The patient presented with West syndrome, severe psychomotor delay, failure to thrive, microcephaly, atypical ocular movements, and pyramidal signs. Treatment with oral L-serine abolished seizures and improved psychomotor development, hyperexcitability, head growth, cortical and subcortical hypotrophy, and hypomyelination of the brain on MRI scans. 3-phosphoglycerate dehydrogenase deficiency is a treatable congenital error that probably leads to West syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / pathology
  • Carbohydrate Dehydrogenases / deficiency*
  • Electroencephalography
  • Failure to Thrive
  • Female
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Motor Skills Disorders / drug therapy
  • Motor Skills Disorders / etiology
  • Phosphoglycerate Dehydrogenase
  • Seizures / etiology
  • Serine / therapeutic use*
  • Spasms, Infantile / drug therapy
  • Spasms, Infantile / etiology*
  • Spasms, Infantile / physiopathology
  • Treatment Outcome

Substances

  • Serine
  • Carbohydrate Dehydrogenases
  • Phosphoglycerate Dehydrogenase